alexa Investigating DYS Functional-HDL In Selected Groups Of Patients At High Risk Of Cardiovascular Events (DYS-HDL Study) - Protocol And Organization
ISSN-2155-9929

Journal of Molecular Biomarkers & Diagnosis
Open Access

Like us on:
OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations

700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Share This Page

Additional Info

Loading
Loading Please wait..
 

5th International Conference on Biomarkers & Clinical Research
April 15-17, 2014 St. Hilda’s College - University of Oxford, UK

Maciej Banach
Accepted Abstracts: J Mol Biomark Diagn
DOI: 10.4172/2155-9929.S1.023
Abstract
Introduction and Objectives: Different clinical conditions associated with inflammation and oxidation can alter HDL functionality, converting them into dysfunctional HDL. It may lead to the impairment of reverse cholesterol transport and might exhibit pro-inflammatory, pro-oxidant, and pro-thrombotic properties. The main aim of the study is to investigate the occurrence of dysfunctional HDL in a selected group of patients. We will also assess subfractions of HDL-C that may have impaired antiatherogenic function, and their predictive role for clinical events. Protocol: 500 consecutive patients will be included in the study- 125 patients in each group: (1): with hypertension and other CAD risk factors; (2): with DMt2; (3): with established CAD; and (4): with chronic kidney disease in stage 1-4. After evaluating of patients? overall CV risk they will receive atorvastatin at a suitable dose (20-80 mg/day- according to ESC/EAS 2011 guidelines). Patients will attend clinic visits after 6 months and next at 12-month intervals and will be contacted by telephone in alternate quarterly intervals. The mean follow-up will be 42 months. The primary outcome will be defined as the time from inclusion to the first occurrence of any of the following events: CHD death, coronary event or coronary procedure. Dysfunctional-HDL analysis will be performed by the detailed detection of the nitration and chlorination sites using a Q-ToF Premier mass spectrometer system equipped with nanoACQUITY UPLC system. HDL subfractions/subpopulation analyses will be performed by the LipopPrint test and NMR Lipotest. miRNA profiles within HDL fractions will be studied with quantitative PCR techniques. Organization: General Coordinating Centre is in Lodz, Poland (Medical University of Lodz). The Executive Committee is composed of international lipid experts from Europe and USA, who form the Steering Committee.
Biography
Maciej Banach was an Undersecretary of State at Ministry of Science and Higher Education of Republic of Poland (2010-2012). He is Professor of Medicine at Medical University of Lodz, Head of Foreign Affairs Office (2012-Present) and Head of Department of Hypertension (2008-Present) at Medical University of Lodz and Professor in the Department of Nephrology, Hypertension and Family Medicine, Chair of Nephrology and Hypertension, at WAM University Hospital in Lodz, Poland. He is a Founder and Head of Polish Lipid Association (PoLA) (2011-Present) - the official partner of National Lipid Association (NLA, US) and Lodz Chapter of Polish Society of Hypertension (2009-Present). Dr. Banach is a fellow of the Council for High Blood Pressure Research of American Heart Association (FAHA), National Lipid Association (FNLA), American Society of Angiology (FASA), European Society of Cardiology (FESC), Royal Society for Public Health (FRSPH) and Society of Geriatric Cardiology (FSGC; 2008-2010). He is a founder of Lipid and Blood Pressure Meta-analysis Collaboration (LBPMC) Group, member of working- core of Alliance for Biomedical Research/European Council for Health Research, steering committee of European Innovation Partnership in Active and Healthy Ageing (2010-2012) at European Commission (Brussels), and steering committee of Centre for Good Aging/Healthy Ageing Research Center (HARC) at Medical University of Lodz, member of Committee for Public Health of Polish Academy of Sciences. His main area of scientific interests concerns hypertension aspects (risk stratification, prehypertension, new biomarkers, optimal level of BP - J-curve phenomenon, pharmacotherapy/combined therapy, prevention, complications), lipid disorders (risk stratification, new biomarkers, diagnosis, rare diseases), dyslipidemia therapy (statins, new drugs combined treatment), new drugs in CVD therapy.
image PDF   |   image HTML
 

Relevant Topics

Peer Reviewed Journals
 
Make the best use of Scientific Research and information from our 700 + peer reviewed, Open Access Journals
International Conferences 2017-18
 
Meet Inspiring Speakers and Experts at our 3000+ Global Annual Meetings

Contact Us

Agri & Aquaculture Journals

Dr. Krish

[email protected]

1-702-714-7001Extn: 9040

Biochemistry Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Business & Management Journals

Ronald

[email protected]

1-702-714-7001Extn: 9042

Chemistry Journals

Gabriel Shaw

[email protected]

1-702-714-7001Extn: 9040

Clinical Journals

Datta A

[email protected]

1-702-714-7001Extn: 9037

Engineering Journals

James Franklin

[email protected]

1-702-714-7001Extn: 9042

Food & Nutrition Journals

Katie Wilson

[email protected]

1-702-714-7001Extn: 9042

General Science

Andrea Jason

[email protected]

1-702-714-7001Extn: 9043

Genetics & Molecular Biology Journals

Anna Melissa

[email protected]line.com

1-702-714-7001Extn: 9006

Immunology & Microbiology Journals

David Gorantl

[email protected]

1-702-714-7001Extn: 9014

Materials Science Journals

Rachle Green

[email protected]

1-702-714-7001Extn: 9039

Nursing & Health Care Journals

Stephanie Skinner

[email protected]

1-702-714-7001Extn: 9039

Medical Journals

Nimmi Anna

[email protected]

1-702-714-7001Extn: 9038

Neuroscience & Psychology Journals

Nathan T

[email protected]

1-702-714-7001Extn: 9041

Pharmaceutical Sciences Journals

Ann Jose

[email protected]

1-702-714-7001Extn: 9007

Social & Political Science Journals

Steve Harry

[email protected]

1-702-714-7001Extn: 9042

 
© 2008- 2017 OMICS International - Open Access Publisher. Best viewed in Mozilla Firefox | Google Chrome | Above IE 7.0 version
adwords